Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 12 September 2027
- Last conf. stmt
- 29 August 2026
Coiled Therapeutics PLC
- Incorporated
- 17 August 2020 (6 years)
- Previously known as
- Roquefort Therapeutics PLC (until 26 March 2026)Roquefort Investments PLC (until 30 December 2021)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Craig Allen ToomanAndrew Peter DeanSotirios Stergiopoulos
- Accounts type
- Group
- Region
- Greater London
- Address
- 167-169 Great Portland Street5th FloorLondonW1W 5PF
Officers 7 active
Officer details are public data from the Companies House register.
Tooman, Craig Allen
Director · Appointed 25 June 2026
American
Born October 1965 (61)
Dean, Andrew Peter, Dr
Director · Appointed 7 May 2026
Australian,British
Born July 1962 (64)
Stergiopoulos, Sotirios, Dr
Director · Appointed 27 March 2026
American
Born April 1971 (55)
Vempati, Sridhar
Director · Appointed 27 March 2026
American
Born August 1977 (49)
Duvall, Jean Marie
Director · Appointed 5 April 2022
Swiss
Born June 1961 (65)
Corporate Secretary · Appointed 15 December 2021
Director · Appointed 17 August 2020
British,Australian
Born October 1972 (54)
Officer history (9 former)
25 June 2026
Appointed Tooman, Craig Allen as Director
7 May 2026
Appointed Dean, Andrew Peter, Dr as Director
27 March 2026
Appointed Stergiopoulos, Sotirios, Dr as Director
27 March 2026
Appointed Vempati, Sridhar as Director
27 March 2026
Resigned Sinclair, Simon Rupert, Dr as Director
27 March 2026
Resigned Disley, Darrin Matthew, Dr as Director
17 March 2025
17 March 2025
23 May 2024
16 September 2022
16 September 2022
Appointed Disley, Darrin Matthew, Dr as Director
16 September 2022
16 September 2022
20 April 2022
Appointed Sinclair, Simon Rupert, Dr as Director
5 April 2022
Appointed Duvall, Jean Marie as Director
4 April 2022
Resigned Rollins, Mark Andrew as Director
15 December 2021
Resigned West, Stephen Paul as Secretary
15 December 2021
20 October 2021
20 October 2021
Resigned Whiddon, Glenn Ross as Director
22 March 2021
2 November 2020
Appointed Rollins, Mark Andrew as Director
17 August 2020
Appointed Whiddon, Glenn Ross as Director
17 August 2020
Appointed West, Stephen Paul as Secretary
17 August 2020
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Holdings 2
Companies where Coiled Therapeutics PLC is registered as a person with significant control
Owns 75–100% of shares
Active
Owns 75–100% of shares
Proposed for strike-off
Former controllers (2)
22 March 2021
22 March 2021
Ceased Glenn Ross Whiddon — Owns 25–50% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 4 September 2026 | Confirmation statement with updates | 29 August 2026 | ||
| 19 August 2026 | Appointment of a director | |||
| 10 August 2026 | Registered office address changed | |||
| 9 August 2026 | Director's details changed |
Other companies at this postcode
Over 1,000 have been registered at this postcode.
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →